Vera Therapeutics’ stock could rise by 70%, according to Wall Street analysts

[cafead]

via

• Vera Therapeutics is a clinical stage company that some analysts think could be worth $1 billion.
• The company could have an approved product for the treatment of IgA nephropathy by 2026.
• It believes it has the cash and credit necessary for it to fund its business for the next few years.

article source